J&J asks doctors to limit Natrecor use
In an effort to curb off-label use of its heart failure drug Natrecor, Johnson & Johnson’s Scios division has unveiled ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.